Antidementia drug prescription sources and patterns after the diagnosis of dementia in Germany: results of a claims data-based 1-year follow-up.
about
'Big data' in mental health research: current status and emerging possibilitiesPersistence and adherence with dementia pharmacotherapy: relevance of patient, provider, and system factorsAre community-living and institutionalized dementia patients cared for differently? Evidence on service utilization and costs of care from German insurance claims data.Dosage strength is associated with medication persistence with Ginkgo biloba drug products: a cohort study of ambulatory drug claims data in Germany.Risk of Long-Term Care Dependence for Dementia Patients is Associated with Type of Physician: An Analysis of German Health Claims Data for the Years 2006 to 2010.Regular Benzodiazepine and Z-Substance Use and Risk of Dementia: An Analysis of German Claims Data.Antidementia drug use among community-dwelling individuals with Alzheimer's disease in Finland: a nationwide register-based studyA Real-world Analysis of Treatment Patterns for Cholinesterase Inhibitors and Memantine among Newly-diagnosed Alzheimer's Disease Patients.Impact of geriatric comorbidity and polypharmacy on cholinesterase inhibitors prescribing in dementia.Antidementia drug treatment in dementia networks in Germany: use rates and factors associated with treatment use.Cost-effectiveness of cerebrospinal biomarkers for the diagnosis of Alzheimer's diseasePrescribing of antipsychotic drugs in patients with dementia: a comparison with age-matched and sex-matched non-demented controls.Treatment Patterns with Antidementia Drugs in the United States: Medicare Cohort Study.Continuous treatment with antidementia drugs in Germany 2003-2013: a retrospective database analysis.The cholinergic system in the pathophysiology and treatment of Alzheimer's disease
P2860
Q26741297-4A8B70CD-4A99-4880-8DD0-75E7A72515F2Q26997299-D9BC5998-990B-4FAD-901F-ED904711D659Q30584422-638F83D1-33DB-49C9-A659-3B88D1897964Q30683521-3FC0CA30-BCBB-4CF7-8BB0-1049DE0CA8CCQ30996681-03B8C6F6-75B0-476C-BDDE-1033EE6416A9Q31124452-3E2412E1-3EE3-4C64-BC9A-6139E0C4020DQ33718205-4012CC5D-782E-4F93-B3B1-11856D00F56DQ33736233-24CB1752-7512-4082-9453-97CA886E7E13Q34092726-C31446D8-B687-4627-B491-DF6E664E1B37Q35638635-484A5AA8-B766-4A9A-9401-86A99D4F81C6Q37708297-49877E2D-3E74-4B5A-9CBA-84A74E70E992Q38152394-7CB11956-5201-457C-9443-36443072122AQ39657233-8BE386A2-7094-483F-9F0C-76792EA0C391Q41032305-4FF839FC-F563-48BF-B18A-563CB22D23BFQ57177786-C4714D59-F2E7-4028-9D62-AF3733A96A87
P2860
Antidementia drug prescription sources and patterns after the diagnosis of dementia in Germany: results of a claims data-based 1-year follow-up.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Antidementia drug prescription ...... s data-based 1-year follow-up.
@ast
Antidementia drug prescription ...... s data-based 1-year follow-up.
@en
type
label
Antidementia drug prescription ...... s data-based 1-year follow-up.
@ast
Antidementia drug prescription ...... s data-based 1-year follow-up.
@en
prefLabel
Antidementia drug prescription ...... s data-based 1-year follow-up.
@ast
Antidementia drug prescription ...... s data-based 1-year follow-up.
@en
P2093
P1476
Antidementia drug prescription ...... s data-based 1-year follow-up.
@en
P2093
Birgitt Wiese
Daniela Koller
Gerd Glaeske
Hendrik van den Bussche
Marion Eisele
Susanne Steinmann
P304
P356
10.1097/YIC.0B013E328344C600
P577
2011-07-01T00:00:00Z